Inventor
BORODOVSKY ANNA
US21 patents
⚠️ This page may combine multiple inventors who share the name “BORODOVSKY ANNA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALNYLAM PHARMACEUTICALS INC
17 patentsUS9249415B2Feb 2, 2016
Complement component C5 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC24 citations94
US9850488B2Dec 26, 2017
Complement component C5 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC11 citations92
US10465194B2Nov 5, 2019
Complement component iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC11 citations84
US10125369B2Nov 13, 2018
PCSK9 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC9 citations84
US9701963B2Jul 11, 2017
Complement component C5 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC9 citations84
US11873491B2Jan 16, 2024
Complement component C5 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC2 citations73
US11866701B2Jan 9, 2024
Complement component C3 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC2 citations73
US11186842B2Nov 30, 2021
Complement component iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC4 citations73
US11162098B2Nov 2, 2021
Complement component C5 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC2 citations73
US7759320B2Jul 20, 2010
Compositions and methods for inhibiting expression of a gene from the Ebola
ALNYLAM PHARMACEUTICALS INC6 citations73
US11326166B1May 10, 2022
Xanthine dehydrogenase (XDH) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC3 citations72
US12590305B2Mar 31, 2026
Complement component C5 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC0 citations62
US12460206B2Nov 4, 2025
PCSK9 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC0 citations62
US8735369B2May 27, 2014
Compositions and methods for inhibiting expression of a gene from the Ebola virus
ALNYLAM PHARMACEUTICALS INC1 citations62
US9187516B2Nov 17, 2015
Compositions and methods for inhibiting expression of a gene from the Ebola virus
ALNYLAM PHARMACEUTICALS INC0 citations51
US8354390B2Jan 15, 2013
Compositions and methods for inhibiting expression of a gene from the ebola virus
ALNYLAM PHARMACEUTICALS INC0 citations51
US7973020B2Jul 5, 2011
Compositions and methods for inhibiting expression of a gene from the ebola virus
ALNYLAM PHARMACEUTICALS INC0 citations51
DE FOUGEROLLES ANTONIN
3 patentsUS9029338B2May 12, 2015
Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
DE FOUGEROLLES ANTONIN1 citations51
US8912316B2Dec 16, 2014
Compositions and methods for inhibiting expression of CD45 gene
DE FOUGEROLLES ANTONIN0 citations51
US8288525B2Oct 16, 2012
Compositions and methods for inhibiting expression of CD45 gene
DE FOUGEROLLES ANTONIN1 citations51